insights_auto
Zakaj je tečaj MRK zrasel 2,26%?
Podrobneje raziščichevron_right
MRK:NYSE
Merck Sharp & Dohme
145,60 $
arrow_upward
+2,26%(+3,22) 1D
146,31 $
arrow_upward
+0,49% (+0,71)bedtimePo zaprtju
Zaprto: 9. okt., 16:02:34 GMT -4 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za MRK …
Odpri
141,37 $
Visoka
146,68 $
Nizka
141,36 $
Tržna kapitalizacija
359,22 mrd.
Povprečni promet
9,40 mio.
Promet
9,29 mio.
Dividenda
2,34 %
Četrtletna dividenda
0,85 $
Prvi trgovalni dan brez upravičenja do dividende
15. sep. 2026
Razmerje med ceno delnice in čistim dobičkom
116,29
52-tedenski najvišji tečaj
156,92 $
52-tedenski najnižji tečaj
82,01 $
Čisti dobiček na delnico
1,25 $
Beta
0,21
Št. izdanih delnic
2,47 mrd.
Št. zaposlenih
74 tis.
Odpri
141,37 $
Visoka
146,68 $
Nizka
141,36 $
Tržna kapitalizacija
359,22 mrd.
Povprečni promet
9,40 mio.
Promet
9,29 mio.
Dividenda
2,34 %
Četrtletna dividenda
0,85 $
Prvi trgovalni dan brez upravičenja do dividende
15. sep. 2026
Razmerje med ceno delnice in čistim dobičkom
116,29
52-tedenski najvišji tečaj
156,92 $
52-tedenski najnižji tečaj
82,01 $
Čisti dobiček na delnico
1,25 $
Beta
0,21
Št. izdanih delnic
2,47 mrd.
Št. zaposlenih
74 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
TIKR.com
·
pred 2 urama
Merck Stock Is Up 38% in 2026 as Investors Pay More for Flat Near-Term Earnings. Here’s Where the Stock Could Go by 2030
Investing.com Nigeria
·
pred 18 urami
Merck’s remigromig meets non-inferiority goal in DME trial By Investing.com
The Globe and Mail
·
pred 1 dnevom
Merck & Company (MRK) Receives a Buy from UBS
MarketBeat
·
pred 1 dnevom
Merck & Co., Inc. $MRK Shares Sold by Castle Rock Wealth Management LLC
Profil
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
Vizitka: Merck Sharp & Dohme
Generalni direktorRobert M Davis
Št. zaposlenih74 tis.
Ustanovljeno1. jan. 1891
Sedež-
Sektor-
Spletno mestomerck.com